Annual Total Expenses:
$10.11B+$1.23B(+13.80%)Summary
- As of today, REGN annual total expenses is $10.11 billion, with the most recent change of +$1.23 billion (+13.80%) on December 31, 2024.
- During the last 3 years, REGN annual total expenses has risen by +$3.03 billion (+42.86%).
- REGN annual total expenses is now at all-time high.
Performance
REGN Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Expenses:
$2.29B+$10.30M(+0.45%)Summary
- As of today, REGN quarterly total expenses is $2.29 billion, with the most recent change of +$10.30 million (+0.45%) on September 30, 2025.
- Over the past year, REGN quarterly total expenses has dropped by -$85.80 million (-3.60%).
- REGN quarterly total expenses is now -20.10% below its all-time high of $2.87 billion, reached on December 31, 2024.
Performance
REGN Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
REGN Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +13.8% | -3.6% |
| 3Y3 Years | +42.9% | +41.6% |
| 5Y5 Years | +132.5% | +58.0% |
REGN Total Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +42.9% | -20.1% | +41.6% |
| 5Y | 5-Year | at high | +132.5% | -20.1% | +80.1% |
| All-Time | All-Time | at high | >+9999.0% | -20.1% | +4211.3% |
REGN Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $2.29B(+0.5%) |
| Jun 2025 | - | $2.28B(+2.9%) |
| Mar 2025 | - | $2.22B(-22.7%) |
| Dec 2024 | $10.11B(+13.8%) | $2.87B(+20.6%) |
| Sep 2024 | - | $2.38B(+12.5%) |
| Jun 2024 | - | $2.11B(-12.7%) |
| Mar 2024 | - | $2.42B(+6.5%) |
| Dec 2023 | $8.88B(+23.8%) | $2.27B(-3.4%) |
| Sep 2023 | - | $2.35B(+7.5%) |
| Jun 2023 | - | $2.19B(-6.6%) |
| Mar 2023 | - | $2.34B(+5.7%) |
| Dec 2022 | $7.18B(+1.4%) | $2.22B(+36.8%) |
| Sep 2022 | - | $1.62B(-19.2%) |
| Jun 2022 | - | $2.01B(+0.7%) |
| Mar 2022 | - | $1.99B(-26.9%) |
| Dec 2021 | $7.08B(+43.8%) | $2.72B(+49.5%) |
| Sep 2021 | - | $1.82B(-10.7%) |
| Jun 2021 | - | $2.04B(+44.3%) |
| Mar 2021 | - | $1.41B(+11.0%) |
| Dec 2020 | $4.92B(+13.2%) | $1.27B(-12.3%) |
| Sep 2020 | - | $1.45B(+37.7%) |
| Jun 2020 | - | $1.05B(-12.4%) |
| Mar 2020 | - | $1.20B(+12.3%) |
| Dec 2019 | $4.35B(+66.5%) | $1.07B(-0.2%) |
| Sep 2019 | - | $1.07B(-22.4%) |
| Jun 2019 | - | $1.38B(+51.9%) |
| Mar 2019 | - | $911.50M(-17.7%) |
| Dec 2018 | $2.61B(-31.2%) | $1.11B(+3.6%) |
| Sep 2018 | - | $1.07B(+1.2%) |
| Jun 2018 | - | $1.06B(+2.2%) |
| Mar 2018 | - | $1.03B(-26.6%) |
| Dec 2017 | $3.79B(+7.4%) | $1.41B(+26.7%) |
| Sep 2017 | - | $1.11B(+2.8%) |
| Jun 2017 | - | $1.08B(+1.2%) |
| Mar 2017 | - | $1.07B(+9.9%) |
| Dec 2016 | $3.53B(+23.8%) | $973.71M(+1.9%) |
| Sep 2016 | - | $955.32M(-6.0%) |
| Jun 2016 | - | $1.02B(-0.3%) |
| Mar 2016 | - | $1.02B(+8.1%) |
| Dec 2015 | $2.85B(+42.9%) | $943.08M(+1.7%) |
| Sep 2015 | - | $927.02M(+15.3%) |
| Jun 2015 | - | $803.97M(+1.3%) |
| Mar 2015 | - | $793.59M(+14.7%) |
| Dec 2014 | $2.00B(+46.6%) | $692.15M(+7.1%) |
| Sep 2014 | - | $646.07M(+12.8%) |
| Jun 2014 | - | $572.97M(+2.3%) |
| Mar 2014 | - | $560.30M(+9.1%) |
| Dec 2013 | $1.36B(+47.9%) | $513.61M(+12.7%) |
| Sep 2013 | - | $455.72M(+23.1%) |
| Jun 2013 | - | $370.27M(+8.6%) |
| Mar 2013 | - | $340.79M(+710.7%) |
| Dec 2012 | $920.76M(+41.4%) | -$55.80M(-123.6%) |
| Sep 2012 | - | $236.22M(+3.8%) |
| Jun 2012 | - | $227.66M(+3.4%) |
| Mar 2012 | - | $220.14M(+24.8%) |
| Dec 2011 | $650.98M(+17.0%) | $176.42M(+6.8%) |
| Sep 2011 | - | $165.20M(-3.0%) |
| Jun 2011 | - | $170.31M(+9.4%) |
| Mar 2011 | - | $155.65M(+5.0%) |
| Dec 2010 | $556.55M(+22.8%) | $148.27M(+6.0%) |
| Sep 2010 | - | $139.85M(-1.1%) |
| Jun 2010 | - | $141.36M(+5.4%) |
| Mar 2010 | - | $134.06M(+0.6%) |
| Dec 2009 | $453.37M(+39.6%) | $133.29M(+12.5%) |
| Sep 2009 | - | $118.47M(+12.9%) |
| Jun 2009 | - | $104.97M(+16.2%) |
| Mar 2009 | - | $90.37M(+3.5%) |
| Dec 2008 | $324.71M | $87.36M(+0.8%) |
| Sep 2008 | - | $86.70M(+9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2008 | - | $79.11M(+16.3%) |
| Mar 2008 | - | $68.00M(-12.6%) |
| Dec 2007 | $239.48M(+40.0%) | $77.80M(+33.8%) |
| Sep 2007 | - | $58.15M(+18.7%) |
| Jun 2007 | - | $48.97M(+7.1%) |
| Mar 2007 | - | $45.70M(+10.6%) |
| Dec 2006 | $171.10M(+393.8%) | $41.32M(-4.0%) |
| Sep 2006 | - | $43.03M(+0.5%) |
| Jun 2006 | - | $42.83M(+8.7%) |
| Mar 2006 | - | $39.41M(-16.3%) |
| Dec 2005 | -$58.23M(-134.6%) | $47.10M(-7.4%) |
| Sep 2005 | - | $50.85M(+17.3%) |
| Jun 2005 | - | $43.37M(+113.3%) |
| Mar 2005 | - | $20.33M(-54.1%) |
| Dec 2004 | $168.37M(+6.9%) | $44.30M(-6.9%) |
| Sep 2004 | - | $47.59M(+10.8%) |
| Jun 2004 | - | $42.97M(+1790.3%) |
| Mar 2004 | - | -$2.54M(-106.3%) |
| Dec 2003 | $157.49M(+9.4%) | $40.65M(-9.2%) |
| Sep 2003 | - | $44.79M(+14.1%) |
| Jun 2003 | - | $39.27M(-2.4%) |
| Mar 2003 | - | $40.25M(-0.9%) |
| Dec 2002 | $143.94M(+33.7%) | $40.60M(+3.1%) |
| Sep 2002 | - | $39.38M(+9.4%) |
| Jun 2002 | - | $35.99M(+18.4%) |
| Mar 2002 | - | $30.39M(-7.3%) |
| Dec 2001 | $107.66M(+27.3%) | $32.78M(+29.0%) |
| Sep 2001 | - | $25.41M(+23.3%) |
| Jun 2001 | - | $20.61M(+6.5%) |
| Mar 2001 | - | $19.35M(-30.6%) |
| Dec 2000 | $84.55M(+45.0%) | $27.87M(+90.7%) |
| Sep 2000 | - | $14.62M(-16.0%) |
| Jun 2000 | - | $17.40M(-2.3%) |
| Mar 2000 | - | $17.82M(+34.2%) |
| Dec 1999 | $58.30M(+14.8%) | $13.27M(-18.2%) |
| Sep 1999 | - | $16.23M(+8.1%) |
| Jun 1999 | - | $15.00M(+4.3%) |
| Mar 1999 | - | $14.39M(+9.7%) |
| Dec 1998 | $50.80M(+25.1%) | $13.12M(+7.5%) |
| Sep 1998 | - | $12.20M(-6.5%) |
| Jun 1998 | - | $13.05M(+8.1%) |
| Mar 1998 | - | $12.08M(+18.4%) |
| Dec 1997 | $40.60M(-1.9%) | $10.20M(+2.0%) |
| Sep 1997 | - | $10.00M(-2.9%) |
| Jun 1997 | - | $10.30M(0.0%) |
| Mar 1997 | - | $10.30M(-6.4%) |
| Dec 1996 | $41.40M(+18.3%) | $11.00M(+3.8%) |
| Sep 1996 | - | $10.60M(+7.1%) |
| Jun 1996 | - | $9.90M(0.0%) |
| Mar 1996 | - | $9.90M(+16.5%) |
| Dec 1995 | $35.00M(-33.2%) | $8.50M(-1.2%) |
| Sep 1995 | - | $8.60M(-3.4%) |
| Jun 1995 | - | $8.90M(-1.1%) |
| Mar 1995 | - | $9.00M(-29.7%) |
| Dec 1994 | $52.40M(+6.1%) | $12.80M(+1.6%) |
| Sep 1994 | - | $12.60M(-7.4%) |
| Jun 1994 | - | $13.60M(+1.5%) |
| Mar 1994 | - | $13.40M(-5.0%) |
| Dec 1993 | $49.40M(+65.8%) | $14.10M(+9.3%) |
| Sep 1993 | - | $12.90M(+16.2%) |
| Jun 1993 | - | $11.10M(-1.8%) |
| Mar 1993 | - | $11.30M(+34.5%) |
| Dec 1992 | $29.80M(+76.3%) | $8.40M(+5.0%) |
| Sep 1992 | - | $8.00M(+19.4%) |
| Jun 1992 | - | $6.70M(0.0%) |
| Mar 1992 | - | $6.70M(+17.5%) |
| Dec 1991 | $16.90M(+103.6%) | $5.70M(+29.5%) |
| Sep 1991 | - | $4.40M(+18.9%) |
| Jun 1991 | - | $3.70M |
| Dec 1990 | $8.30M | - |
FAQ
- What is Regeneron Pharmaceuticals, Inc. annual total expenses?
- What is the all-time high annual total expenses for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. annual total expenses year-on-year change?
- What is Regeneron Pharmaceuticals, Inc. quarterly total expenses?
- What is the all-time high quarterly total expenses for Regeneron Pharmaceuticals, Inc.?
- What is Regeneron Pharmaceuticals, Inc. quarterly total expenses year-on-year change?
What is Regeneron Pharmaceuticals, Inc. annual total expenses?
The current annual total expenses of REGN is $10.11B
What is the all-time high annual total expenses for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high annual total expenses is $10.11B
What is Regeneron Pharmaceuticals, Inc. annual total expenses year-on-year change?
Over the past year, REGN annual total expenses has changed by +$1.23B (+13.80%)
What is Regeneron Pharmaceuticals, Inc. quarterly total expenses?
The current quarterly total expenses of REGN is $2.29B
What is the all-time high quarterly total expenses for Regeneron Pharmaceuticals, Inc.?
Regeneron Pharmaceuticals, Inc. all-time high quarterly total expenses is $2.87B
What is Regeneron Pharmaceuticals, Inc. quarterly total expenses year-on-year change?
Over the past year, REGN quarterly total expenses has changed by -$85.80M (-3.60%)